MicroVision Announces Third Quarter 2018 Results

REDMOND, Wash., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MicroVision, Inc. (NASDAQ:MVIS), a leader in innovative ultra-miniature projection display and sensing technology, today announced results for the quarter ended September 30, 2018.

Revenue for the third quarter of 2018 was $11.6 million, compared to $5.4 million for the third quarter of 2017. MicroVision's net profit for the third quarter of 2018 was $0.3 million, or $0.00 per share, compared to a net loss of $5.8 million, or $0.08 per share for the third quarter of 2017.

“I am pleased with the progress we made in Q3 while targeting Tier 1 technology leaders who have the capabilities to bring our innovative solutions to market. During the quarter, we completed the technology transfer to our display-only licencee that we announced in May and continue to make significant progress on our product development,” said Perry Mulligan, MicroVision’s Chief Executive Officer. “Based on the team’s execution, I believe we are positioned to potentially support the launch of three product families during the second half of 2019, which could position us to achieve profitability in late 2019. To support these product launches, we are now working with our module manufacturing partner to be ready for our 2019 sales opportunities and to minimize the associated working capital requirements,” Perry added.

The company has implemented Revenue Standard ASC 606 for the year beginning January 1, 2018. The Company transitioned to the new standard using the full retrospective approach, and per the standard, historical periods have been adjusted as if the new standard was in place for historical periods.

Financial Results Conference Call

The company will host a conference call today to discuss its third quarter 2018 results and current business operations at 5:00 p.m. ET/2:00 p.m. PT. Interested parties can listen to the company's conference call by accessing the MicroVision website’s Investor Events Calendar page or dialing 1-877-883-0383 (for U.S. participants) or 1-412-902-6506  (for participants outside the U.S.) ten minutes prior to the start of the call using pass code number 4343681. A replay webcast of the call will also be available from the MicroVision website’s Investor Events Calendar page.

About MicroVision

MicroVision is the creator of PicoP® scanning technology, an ultra-miniature sensing and projection solution based on the laser beam scanning methodology pioneered by the company. MicroVision’s platform approach for this sensing and display solution means that its technology can be adapted to a wide array of applications and form factors. We combine our hardware, software, and algorithms to unlock value for our customers by providing them a differentiated advanced solution for a rapidly evolving, always-on world.

Extensive research has led MicroVision to become an independently recognized leader in the development of intellectual property. MicroVision’s IP portfolio has been recognized by the Patent Board as a top 50 IP portfolio among global industrial companies and has been included in the Ocean Tomo 300 Patent Index. The company is based in Redmond, Washington.

For more information, visit the company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc or follow MicroVision on Twitter at @MicroVision.

MicroVision® and PicoP® are registered trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Forward-Looking Statements

Certain statements contained in this release, including those relating to executing milestones, progress on product development, future product and product applications, potential demand for MicroVision technology and products,  the potential launch of new products, support of module manufacturing partners, minimizing working capital, achieving profitability and those containing words such as “believe,” and “could,” are forward-looking statements that involve risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: our ability to raise additional capital when needed; products incorporating our PicoP display technology may not achieve market acceptance, commercial partners may not perform under agreements as anticipated, we may be unsuccessful in identifying parties interested in paying any amounts or amounts we deem desirable for the purchase or license of IP assets, our or our customers' failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; and other risk factors identified from time to time in the company's SEC reports, including the company's Annual Report on Form 10-K filed with the SEC. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

 
MicroVision, Inc.
Balance Sheet
(In thousands)
(Unaudited)
    September 30,   December 31,
    2018
  2017
         
Assets        
Current Assets        
Cash and cash equivalents   $ 13,210     $ 16,966  
Accounts receivable, net     5,044       15  
Costs and estimated earnings in excess of billings on uncompleted contracts   1,080       680  
Inventory     3,347       4,541  
Other current assets     893       1,015  
Total current assets     23,574       23,217  
         
Property and equipment, net     2,954       3,251  
Restricted cash     435       435  
Intangible assets, net     515       602  
Other assets     2,492       2,262  
Total assets   $ 29,970     $ 29,767  
         
         
Liabilities and Shareholders' Equity        
Current Liabilities        
Accounts payable   $ 1,631     $ 3,063  
Accrued liabilities     5,719       5,864  
Billings on uncompleted contracts in excess of related costs     1       5  
Other current liabilities     10,027       10,142  
Current portion of capital lease obligations     13       -  
Total current liabilities     17,391       19,074  
         
Capital lease obligations, net of current portion     27       -  
Deferred rent, net of current portion     504       302  
Other long-term liabilities     -       305  
Total liabilities     17,922       19,681  
         
Commitments and contingencies        
         
Shareholders' Equity        
Common stock at par value     93       79  
Additional paid-in capital     546,123       528,873  
Accumulated deficit     (534,168 )     (518,866 )
Total shareholders' equity     12,048       10,086  
Total liabilities and shareholders' equity   $ 29,970     $ 29,767  
         


 
MicroVision, Inc.
Statement of Operations
(In thousands, except earnings per share data)
(Unaudited)
 
         
    Three months ended September 30,   Nine months ended September 30,
    2018   2017
  2018
  2017
                 
                 
Product revenue   $ -   $ 2,253     $ -     $ 2,298  
License and royalty revenue     10,000     77       10,011       280  
Contract revenue     1,572     3,095       5,763       4,754  
Total revenue     11,572     5,425       15,774       7,332  
                             
Cost of product revenue     1,434     3,178       1,998       3,572  
Cost of contract revenue     1,211     2,525       4,201       3,740  
Total cost of revenue     2,645     5,703       6,199       7,312  
                         
Gross margin     8,927     (278 )     9,575       20  
                         
Research and development expense     6,386     3,427       17,905       10,417  
Sales, marketing, general and administrative expense     2,253     2,062       6,953       6,967  
Total operating expenses     8,639     5,489       24,858       17,384  
                         
Income (loss) from operations     288     (5,767 )     (15,283 )     (17,364 )
                 
Other income (expense), net     1     5       (19 )     (3 )
                             
Net income (loss)   $ 289   $ (5,762 )   $ (15,302 )   $ (17,367 )
                             
Net income (loss) per share - basic   $ 0.00   $ (0.08 )   $ (0.18 )   $ (0.25 )
Net income (loss) per share - diluted   $ 0.00   $ (0.08 )   $ (0.18 )   $ (0.25 )
                 
Weighted-average shares outstanding - basic     93,073     74,922       84,388       70,828  
Weighted-average shares outstanding - diluted     93,204     74,922       84,388       70,828  
                 


Investor Relations Contacts

Ted Moreau
Darrow Associates, Inc.
608.298.7369
tmoreau@darrowir.com

or

David H. Allen
Darrow Associates, Inc.
408.427.4463
dallen@darrowir.com

MVIS logo (1).jpg

Source: Microvision, Inc.